期刊文献+

中晚期宫颈鳞状细胞癌同步放化疗敏感性相关血清miRNA的临床研究

The clinical study on simultaneous chemoradiotherapy sensitivity related serum miRNA of middle and advanced cervical squamous cell carcinoma
下载PDF
导出
摘要 目的探讨中晚期宫颈鳞状细胞癌同步放化疗敏感性相关的血清miRNA。方法收集2014年2~12月在我院妇科接受根治性同步放化疗的20例中晚期宫颈癌患者为研究对象,按照患者治疗过程及随访过程中肿瘤评估的情况,将研究对象分为同步放化疗抗拒组(n=10)和同步放化疗敏感组(n=10),筛选抗拒组和敏感组间具有显著表达差异的miRNA,对比两组mi R-136-5p、mi R-152-3p、mi R-206的表达情况。结果在芯片筛选出的miRNA中,抗拒组和敏感组之间具有显著表达差异的miRNA有3个:抗拒组相较敏感组低表达的为mi R-136,抗拒组相较敏感组高表达的为mi R-152和mi R-206。标本定量验证结果显示,敏感组hsa-mi R-136-5p的表达水平高于抗拒组,差异有统计学意义(P<0.01);敏感组hsa-mi R-206的表达水平低于抗拒组,差异有统计学意义(P<0.01);敏感组和抗拒组hsa-mi R-152-3p的表达水平,差异无统计学意义(P>0.05)。结论中晚期宫颈癌患者血清中miRNA-136的表达下调、miRNA-206的表达上调可能与同步放化疗抗拒有关。 Objective To investigate the simultaneous chemoradiotherapy sensitivity related serum miRNAs of middle and advanced cervical squamous cell carcinoma.Methods A total of20patients with middle and advanced cervical squamous cell carcinoma who underwent radical concurrent radiotherapy and chemotherapy from February2014to December2014were enrolled in this study.According to the course of treatment and the evaluation of tumor during follow-up,the subjects were divided into simultaneous chemoradiotherapy resistant group(n=10)and simultaneous chemoradiotherapy sensitive group(n=10).The miRNAs with significant difference in expression between the resistant group and the sensitive group were screened.The expressions of miR-136-5p,miR-152-3p and miR-206were compared between the two groups.Results In the miRNA selected by chip,there were three miRNAs with significant difference between the resistant group and the sensitive group.The expression of miR-136was lower in the resistant group than that in the sensitive group,and the expressions of miR-152and miR-206were higher than those of the sensitive group.Specimen quantitative verification results showed that the expression level of miR-136-5p in sensitive group was higher than that in resistant group,and the difference was significant(P<0.01).The expression level of miR-206in sensitive group was lower than that in resistant group,and the difference was statistically significant(P<0.01).There was no significant difference in the expression level of miR-152-3p between sensitive group and resistant group(P>0.05).Conclusion The downregulation of miRNA-136and upregulation of miRNA-206may be related to the resistance of the simultaneous chemoradiotherapy in patients with middle and advanced cervical squamous cell carcinoma.
作者 钱阅宬 张重寅 张鹏 周钗 吕晓娟 QIAN Yuecheng;ZHANG Zhongyin;ZHANG Peng;ZHOU Chai;LV Xiaojuan(Physics Lab, Zhejiang Provincial Cancer Hospital, Hangzhou 310022,China)
出处 《中国现代医生》 2017年第31期1-4,共4页 China Modern Doctor
基金 浙江省医药卫生一般研究计划(B类)(2015KYB068)
关键词 宫颈鳞状细胞癌 MIRNA 放疗 化疗 敏感性 Cervical squamous cell carcinoma miRNA Radiotherapy Chemotherapy Sensitivity
  • 相关文献

参考文献11

二级参考文献85

  • 1Weihong Li,Yu Guo,Haiyan Niu,Song Jin,Li Wang.Application of TruScreen in detecting ASCUS patients[J].Asian Pacific Journal of Tropical Medicine,2011,4(8):669-671. 被引量:2
  • 2刘嵘,濮德敏,程艳香,尹伶.受体结合肿瘤抗原、血管内皮生长因子和基质金属蛋白酶-9在宫颈癌组织中的表达及其与肿瘤侵袭、转移的关系[J].中华医学杂志,2007,87(19):1326-1329. 被引量:5
  • 3Shay JW, Wright WE. Telomerase activing in human canaer. Current Opinion in oncology, 1996,8:66-71.
  • 4Shay JW, Bacchetii S. A survey of telomerse acti'iity in human cancer. Eur J of Cancer,1997,33:787-792.
  • 5Breslow RA,Shay JW, Gazdar AF, et al. Telomerase and early detection of cancer: a National cancer institute workshop. JNCI, 1997,89:618-625.
  • 6Lee MY, Shen MR. Epithelial-mesenchymal transition in cervical carcinoma[ J ]. Am J Transl Res ,2012,4 ( 1 ) : 1-13.
  • 7Iwatsuki M, Mimori K, Yokobori T, et al. Epithelial-mesenchymal transition in cancer development and its clinical significance [ J]. Cancer Sci ,2010,101 (2) :293-299.
  • 8Olkhanud PB, Damdinsuren B, Bodogai M, et al. Tumor-evoked regulatory B ceils promote breast cancer metastasis by converting resting CIM + T ceils to T regulatory cells[ J]. Cancer Res ,2011, 71 (10) :3505-3515.
  • 9Tian J,Avalos AM, Mao SY, et al. Toll-like receptor 9-dependent activation by DNA-containing immune complexes is mediated by HMGB1 and RAGE[ J]. Nat Immunol,2007,8(5 ) :487-496.
  • 10Sha Y, Amijewski J, Xu Z, et al. HMGB1 develops enhanced proinflammatory activity by binding to cytokines [ J ]. lmmunol, 2008,180(4) :2531-2537.

共引文献164

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部